What is Andromeda?
Andromeda is at the forefront of developing Abi, a personalized robotic companion designed to foster meaningful connections and enhance the capacity of care teams. This Australian-based company is leveraging advanced robotics and AI to create solutions that not only spark joy but also provide tangible support in caregiving environments. The company's focus on personalized interaction and support for care professionals positions it as a key player in the burgeoning field of assistive robotics and AI-driven companionship.
How much funding has Andromeda raised?
Andromeda has raised a total of $28.9M across 2 funding rounds:
Series A
$14.8M
Private Equity
$14.1M
Series A (2025): $14.8M with participation from Forerunner Ventures, Rethink Impact, Main Sequence Ventures, and Artesian
Private Equity (2025): $14.1M, investors not publicly disclosed
Key Investors in Andromeda
Forerunner Ventures
Forerunner Ventures partners with founders to build category-defining companies at the intersection of technology and human behavior, focusing on emerging technology trends and consumer demands to invest in innovative startups.
Rethink Impact
Rethink Impact is a venture capital firm that invests in entrepreneurs and technology platforms focused on creating ecosystems of change, targeting leaders who leverage technology to address significant global challenges.
Main Sequence Ventures
Main Sequence is a venture capital firm focused on deeptech, collaborating with inventors who leverage their scientific expertise to create transformative industries and accelerate the growth of companies addressing significant global challenges.
What's next for Andromeda?
With a recent major strategic investment and a Series A round, Andromeda is poised for significant expansion. The substantial capital infusion is expected to fuel further research and development, enhance manufacturing capabilities, and broaden market reach for Abi. This funding will likely enable Andromeda to scale its operations, refine its technology, and establish a stronger foothold in both domestic and international markets, solidifying its position as a leader in personalized robotic companions and care support solutions.
See full Andromeda company page
